Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000946644-17-000002
Filing Date
2017-02-13
Accepted
2017-02-13 14:45:08
Documents
1
Effectiveness Date
2017-02-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10995
  Complete submission text file 0000946644-17-000002.txt   12180
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-280579 | Film No.: 17598354
SIC: 2836 Biological Products, (No Diagnostic Substances)